Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel HWE reaction route for Afatinib improves purity and supply chain reliability for global pharmaceutical manufacturing partners seeking cost effective solutions.
Patent CN104003828B details a copper complex catalyzed coupling reaction under visible light, offering cost reduction in fine chemical manufacturing and high-purity intermediates.
Patent CN102351870A reveals a novel benzacridine synthesis route targeting c-myc DNA, offering scalable production and cost-effective API intermediate manufacturing solutions.
Patent CN105330652B reveals improved HWE reaction for Afatinib. Enhances purity and supply reliability for global buyers seeking reliable API intermediate suppliers.
Patent CN105732521A reveals a metal-free TEMPO catalytic route for dihydroquinazolinone derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN118324765A reveals a novel Ir-catalyzed route for Duvelisib, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN104045706A reveals fragment coupling for Liraglutide. Enhances purity and yield for reliable supply chain and cost reduction.
Discover the novel palladium-catalyzed intramolecular dearomatization method for indoline quinoline derivatives. Efficient one-pot synthesis for pharmaceutical intermediates.
Patent CN106938995B details asymmetric synthesis for bepotastine besilate. This method offers significant cost reduction and supply chain reliability for ophthalmic drug intermediate manufacturing partners.
Patent CN111394747B details a green electrochemical route for 2-acyloxy aniline derivatives, offering cost reduction in API manufacturing and superior supply chain reliability.
Optimized synthesis route for Tenofovir Alafenamide reduces costs and improves chirality. Reliable supply chain partner for high-purity pharmaceutical intermediates manufacturing.
Patent CN106748906A details high-yield Bumetanide synthesis using Lewis acid. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Novel patent method ensures high purity Sitagliptin free base with significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN102250103A details a robust total synthesis of SN38 from simple materials. This route ensures high purity, scalable production, and supply chain stability for oncology APIs.
Patent CN112028806B reveals a novel synthetic method for Vildagliptin intermediates, achieving 99.7% purity and 80.6% yield through stabilized cyanuric chloride dehydration.
Patent CN105924390B details improved Mei Tafeini synthesis yielding cost reduction in API manufacturing and supply chain reliability for global partners.
Patent CN1740146A reveals efficient synthesis route. Offers high purity and scalable production for pharmaceutical intermediates. Cost-effective manufacturing solution for global supply chains.
Patent CN109517002B reveals a novel synthesis method for cefotiam hydrochloride using boron trifluoride complexes, offering high purity and yield for pharmaceutical manufacturing.
Patent CN105085395A details a novel bedaquiline preparation method improving yield and purity. Offers cost reduction in pharmaceutical manufacturing and scalable supply chain solutions.
Advanced Ir-catalyzed photocross-coupling method for hydrazide compounds. Delivers high purity, mild reaction conditions, and cost-effective manufacturing solutions for reliable global pharmaceutical intermediate supply chains.